Enhancement of red blood cell transfusion compatibility using CRISPR-mediated erythroblast gene editing.
Hawksworth J, Satchwell TJ, Meinders M, Daniels DE, Regan F, Thornton NM, Wilson MC, Dobbe JG, Streekstra GJ, Trakarnsanga K, Heesom KJ, Anstee DJ, Frayne J, Toye AM.
Hawksworth J, et al. Among authors: frayne j.
EMBO Mol Med. 2018 Jun;10(6):e8454. doi: 10.15252/emmm.201708454.
EMBO Mol Med. 2018.
PMID: 29700043
Free PMC article.